Acute Intermittent Porphyria PBMC for Research

Acute Intermittent Porphyria PBMC products are sourced from donors clinically diagnosed with Acute Intermittent Porphyria (AIP) and processed under stringent conditions to support research. These cryopreserved peripheral blood mononuclear cells (PBMCs) enable studies related to heme biosynthesis disorders, including immune dysfunction, cytokine profiling, and cellular stress response mechanisms in AIP.

Product Features

• Research Use Only (RUO), cryopreserved PBMCs
• Clinically confirmed AIP donors
• Processed within 24 hours of collection
• Stored using CryoStore® CS10 freezing media
• IRB-approved protocols and electronic informed consent

Donor Metadata

• Verified AIP diagnosis
• Donor demographics: age, sex assigned at birth, race/ethnicity
• Self-reported allergies and infectious disease history
• Additional AIP-specific data available upon request

Applications

• Biomarker discovery and validation
• Drug screening and therapeutic development
• Immune pathway analysis in Acute Intermittent Porphyria (AIP) pathophysiology
• Transcriptomic and proteomic profiling

Quality and Compliance

• IRB-approved collections and protocols
• 21 CFR Part 11 – compliant e-consent system
• HIPAA-compliant donor data protection

Ordering & Shipping

Acute Intermittent Porphyria PBMC samples are shipped on dry ice and available in custom aliquots. For international orders or regulatory requirements, please contact to confirm documentation and compliance needs.